Ascent Pharmaceuticals, Inc. v. United States Drug Enforcement Administration
| ASCENT PHARMACEUTICALS, INC. |
| UNITED STATES DRUG ENFORCEMENT ADMINISTRATION and UNITED STATES DEPARTMENT OF JUSTICE |
| 23-7246 |
| October 3, 2023 |
| U.S. Court of Appeals, Second Circuit |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 14, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 27 MOTION ORDER, denying motion directing Respondent to approve its 2023 procurement quota application, at docket entry 8, on behalf of Petitioner Ascent Pharmaceuticals, Inc.. This appeal will be expedited. Appellant shall file its brief within 35 days of the date of this order; Appellee shall file its brief within 35 days of the day Appellant's brief is filed; Appellant's reply if any, shall be filed within 10 days of the day Appellee's brief is filed, by RCW, DC, JFB, FILED. [Entered: 11/14/2023 05:08 PM] |
| Filing 26 FRAP 28(j) LETTER, dated , on behalf of Petitioner Ascent Pharmaceuticals, Inc., RECEIVED. Service date 11/13/2023 by ACMS. [Entered: 11/13/2023 04:16 PM] |
| Filing 25 ARGUMENT NOTICE, to attorneys/parties, TRANSMITTED. [Entered: 11/09/2023 11:32 AM] |
| Filing 24 REPLY TO OPPOSITION, on behalf of Petitioner Ascent Pharmaceuticals, Inc., FILED. Service date 10/23/2023 by ACMS. [Entered: 10/23/2023 09:37 PM] |
| Filing 23 OPPOSITION, to Emergency Motion FILED, 8 for injunctive relief, on behalf of Respondent United States Drug Enforcement Administration, FILED. Service date 10/16/2023 by ACMS. [Entered: 10/16/2023 03:50 PM] |
| Filing 22 NEW CASE MANAGER, Elizabeth Munoz, ASSIGNED. [Entered: 10/13/2023 07:32 PM] |
| Filing 21 CAPTION, reflecting the United States Drug Enforcement Administration as the Respondent, AMENDED. [Entered: 10/06/2023 01:37 PM] |
| Filing 20 RESPONDENT United States Department of Justice, TERMINATED. [Entered: 10/06/2023 10:54 AM] [Edited: 10/06/2023 11:03 AM] |
| Filing 19 NEW PARTY, Respondent United States Drug Enforcement Administration for United States Department of Justice, SUBSTITUTED. [Entered: 10/05/2023 03:56 PM] [Edited: 10/06/2023 10:51 AM] |
| Filing 18 ATTORNEY, Lena Watkins, for Respondent United States Department of Justice, TERMINATED. [Entered: 10/05/2023 11:51 AM] |
| Filing 17 ATTORNEY, Mark B. Stern in place of attorney Lena Watkins, SUBSTITUTED. [Entered: 10/05/2023 11:46 AM] |
| Filing 16 ATTORNEY, Benjamin H. Torrance for Respondent United States Department of Justice, TERMINATED. [Entered: 10/05/2023 11:39 AM] |
| Filing 15 ATTORNEY, Urja Mittal, in place of attorney Benjamin Torrance, SUBSTITUTED. [Entered: 10/05/2023 11:31 AM] |
| Filing 14 NOTICE OF APPEARANCE AS SUBSTITUTE COUNSEL/ADDITIONAL COUNSEL, on behalf of United States Department of Justice, FILED. [Entered: 10/04/2023 03:56 PM] |
| Filing 13 NOTICE OF APPEARANCE AS SUBSTITUTE COUNSEL/ADDITIONAL COUNSEL, on behalf of United States Department of Justice, FILED. [Entered: 10/04/2023 03:43 PM] |
| Filing 12 ORAL ARGUMENT STATEMENT LR 34.1 (a), on behalf of Petitioner Ascent Pharmaceuticals, Inc., FILED. Service date 10/04/2023 by ACMS. [Entered: 10/04/2023 11:54 AM] |
| Filing 11 FORM C-A, on behalf of Petitioner Ascent Pharmaceuticals, Inc., FILED. Service date 10/04/2023 by ACMS. [Entered: 10/04/2023 11:49 AM] |
| Filing 10 CURED DEFECTIVE DOCUMENT, Acknowledgment Notice of Appearance Form, at entry 7, on behalf of Petitioner Ascent Pharmaceuticals, Inc., FILED. [Entered: 10/04/2023 11:33 AM] |
| Filing 9 DEFECTIVE DOCUMENT, notice of appearance, at docket entry 6, on behalf of Petitioner Ascent Pharmaceuticals, Inc., FILED. [Entered: 10/04/2023 11:32 AM] |
| Filing 8 MOTION, for oral argument, for___relief, for injunction, on behalf of Petitioner Ascent Pharmaceuticals, Inc., FILED. Service date 10/04/2023 by ACMS. [Entered: 10/04/2023 10:53 AM] |
| Filing 7 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Petitioner Ascent Pharmaceuticals, Inc., FILED. Service date 10/04/2023 by ACMS. [Entered: 10/04/2023 09:21 AM] |
| Filing 6 NOTICE OF APPEARANCE AS SUBSTITUTE COUNSEL/ADDITIONAL COUNSEL, on behalf of Ascent Pharmaceuticals, Inc., FILED. [Entered: 10/03/2023 08:20 PM] |
| Filing 5 PETITION FOR REVIEW OF AGENCY ORDER, SERVED. [Entered: 10/03/2023 06:05 PM] |
| Filing 4 PAYMENT OF DOCKETING FEE, on behalf of Petitioner Ascent Pharmaceuticals, Inc., USCA receipt # A02-2142-ACMS, FILED. [Entered: 10/03/2023 05:52 PM] |
| Filing 3 PETITION FOR REVIEW OF AGENCY ORDER, on behalf of Petitioner Ascent Pharmaceuticals, Inc., OPENED. [Entered: 10/03/2023 05:50 PM] |
| Filing 2 AGENCY DECISION AND ORDER, dated 09/29/2023, RECEIVED. [Entered: 10/03/2023 05:45 PM] |
| Filing 1 PETITION FOR REVIEW OF AGENCY ORDER, on behalf of Petitioner Ascent Pharmaceuticals, Inc., FILED. [Entered: 10/03/2023 05:45 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
